Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy (Record no. 29143)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03065nam a22002657a 4500 |
001 - CONTROL NUMBER | |
control field | 20241012101007.0 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20241012101344.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 241012b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-3-030-56823-8 |
International Standard Book Number | 978-3-030-56824-5 (eBook) |
040 ## - CATALOGING SOURCE | |
Transcribing agency | ddc |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.994 SUA |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Fuller form of name | Maria E. Suarez-Almazor |
245 ## - TITLE STATEMENT | |
Title | Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy |
Remainder of title | A Handbook for Diagnosis and Management. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Department of Health Services Research University of Texas MD Anderson Cancer Center Houston, TX USA | |
Name of publisher, distributor, etc. | Springer Nature Switzerland AG | |
Date of publication, distribution, etc. | 2021. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 361 Pages |
Extent | Includes References |
520 ## - SUMMARY, ETC. | |
Summary, etc. | <br/><br/>With the increasing use of immune checkpoint inhibitors (ICI) across various cancers, the trends for indication at earlier stages, and the use of combination immunotherapy, the frequency of ICI-induced immune-related adverse events (irAE) is expected to grow substantially. Management of these irAE is challenging as it requires not only consideration of the toxicity but also risk-benefit ratios with respect to the primary cancer. Several rheumatic irAE have been reported with ICI therapy including arthritis, myositis, polymyalgia-like syndromes, sicca/Sjogren-like manifestations, and several other less common systemic autoimmune features commonly associated with connective tissue disease.<br/><br/><br/><br/>This handbook provides clinicians with a comprehensive overview of the management of rheumatic irAE that develop from cancer immunotherapy. It focuses on the irAE seen with ICI, the most frequently used agents in treating cancer. It provides an overview of cancer immunology, immunotoxicity, and immunotherapies such as ICI, cytokine-based therapy, and CART. It examines the epidemiology, clinical manifestations, diagnosis, differential diagnosis, and treatment of a variety of rheumatic immune-related adverse events arising from these therapies. Chapters also cover cancer immunotherapy in patients with preexisting rheumatic diseases such as inflammatory arthritis and other connective tissue disorders. The book helps clinicians to distinguish the current types of cancer immunotherapy and general toxicity patterns, recognize and diagnose rheumatic clinical syndromes, understand the pathogenesis of irAE, and consider risk–benefit ratios when managing patients with rheumatic irAE.<br/><br/><br/>Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy is an essential resource for physicians and related professionals, residents, fellows, graduate students and nurses alike in rheumatology, clinical immunology, oncology, and internal medicine. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
General subdivision | Immunology, Medical / Clinical Medicine, Medical / Immunology, Medical / Oncology / General, Medical / Rheumatology, Oncology, Rheumatology, Cancer -- Immunotherapy -- Complications, Immunologic diseases, Rheumatism. |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Fuller form of name | Leonard H. Calabrese |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-3-030-56824-5 ">https://doi.org/10.1007/978-3-030-56824-5 </a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | E-BOOKS |
Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Uniform resource identifier | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/12/2024 | 616.994 SUA | 20241012101007.0 | 10/12/2024 | https://doi.org/10.1007/978-3-030-56824-5 | 10/12/2024 | E-BOOKS |